WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Lung Cancer efficacy endpoints v8, -cough -shortness of breath -chest pain -fatigue -other specifying severity, Karnofsky with allowed values 0, 10, 20...100, Lesion has type New lesion, Therapeutic Efficacy Endpoint is intersection of Therapeutic Intervention, target determined by % staining, Short axis for target lymph nodes measured in mm, Progression free survival (PFS) derived from Tumor Response, score instantiated by - negative: 0 - positive: 1+ 2+ 3+ - other, New lesion identified by Anatomical region, Informational or proposed for removal concepts identified by grey color boxes, Tumor Response assesses Lesion, LD (axial plane) for target lesion measured in mm, Qualitative Assessment have response options -Complete Response (CR) -Non-CR/non-PD -Not evaluated -Not all evaluated -Non-PD -PD -Unequivocal PD -Any, Lung Cancer Type includes NSCLC, Immunohistochemistry has target, Sum of longest diameters (SLD) has component LD (axial plane) for target lesion, - PD associated with Date of tumor progression, Disease characteristics include Lung Cancer Stage, Concepts are denoted by solid round-edged rectangle, Anatomical region instantiated by -Lung -CNS (brain, leptomeninges) -Bone -Liver -Adrenal (L, R) -Mediastinum (anterior, middle, posterior) -Hilar (L, R) -Plural Fluid